Altimmune, Inc. (ALT)
3.11
+0.03
(+0.97%)
USD |
NASDAQ |
Apr 01, 16:00
3.19
+0.08
(+2.57%)
After-Hours: 20:00
Altimmune Research and Development Expense (TTM) : 66.32M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 13.34B |
| CorMedix, Inc. | 19.33M |
| Amgen, Inc. | 7.281B |
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| Viking Therapeutics, Inc. | 344.96M |